slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
815 INR | +8,59% | +1,53% | +24,03% |
Omzet 2024 | 22,83 mld. 274 mln. 256 mln. | Omzet 2025 * | 25,79 mld. 309 mln. 289 mln. | Marktkapitalisatie | 99,85 mld. 1,2 mld. 1,12 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 | 4,71 mld. 56,48 mln. 52,8 mln. | Nettowinst (verlies) 2025 * | 5,5 mld. 66,01 mln. 61,72 mln. | EV/omzet 2024 | 4,17 x |
Nettoliquiditeiten 2024 * | 3,5 mld. 41,96 mln. 39,22 mln. | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 3,87 x |
K/w-verhouding 2024 |
20,2
x | K/w-verhouding 2025 * |
18,2
x | Werknemers | 1.824 |
Dividendrendement 2024 * |
2,59% | Dividendrendement 2025 * |
2,95% | Vrij verhandelbaar | 15,72% |
Recentste transcriptie over Glenmark Life Sciences Limited
1 dag | +8,59% | ||
1 week | +1,53% | ||
Lopende maand | +4,93% | ||
1 maand | +7,27% | ||
3 maanden | -2,54% | ||
6 maanden | +32,23% | ||
Lopend jaar | +24,03% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yasir Rawjee
CEO | Chief Executive Officer | 58 | 13-08-19 |
Director of Finance/CFO | - | 01-06-22 | |
Compliance Officer | - | 23-02-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Manju Agarwal
BRD | Director/Board Member | 66 | 30-10-20 |
Yasir Rawjee
CEO | Chief Executive Officer | 58 | 13-08-19 |
Sumantra Mitra
HRO | Human Resources Officer | 49 | 11-10-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 815 | +8,59% | 584 264 |
25-04-24 | 750,5 | -9,20% | 589 960 |
24-04-24 | 826,5 | +0,03% | 24 936 |
23-04-24 | 826,2 | -1,58% | 88 182 |
22-04-24 | 839,6 | +4,60% | 109 398 |
slotkoers NSE India S.E., 26 april 2024
Meer koersenHerzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+24,03% | 1,2 mld. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |